| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,202 |
1,146 |
$97K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,126 |
1,107 |
$85K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
683 |
658 |
$50K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
435 |
428 |
$49K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
888 |
840 |
$39K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
536 |
395 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
288 |
276 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
383 |
369 |
$3K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
97 |
92 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
28 |
24 |
$2K |
| 99051 |
|
69 |
69 |
$1K |
| 99072 |
|
302 |
283 |
$0.00 |